ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

ImmuneOncia Therapeutics Revenue

ImmuneOncia Therapeutics had revenue of 715.75M KRW in the twelve months ending September 30, 2025. In the year 2024, ImmuneOncia Therapeutics had annual revenue of 654.54M with 495.04% growth.

• Revenue (ttm): 715.75M
• Revenue Growth: +495.04%
• P/S Ratio: 1,141.88
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 817.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	654.54M	544.54M	495.04%
Dec 31, 2023	110.00M	-7.62B	-98.58%
Dec 31, 2022	7.73B	7.70B	21,413.30%
Dec 31, 2021	35.95M	33.45M	1,337.90%
Dec 31, 2020	2.50M	1.00M	66.67%